Brief: Serum Institute Of India Cuts Stake In Panacea Biotec To 3.06% From 5.24% - Exchange Filing
Sept 12 (Reuters) -
* SERUM INSTITUTE OF INDIA CUTS STAKE IN PANACEA BIOTEC TO
3.06%
FROM 5.24% - EXCHANGE FILING
Source text for Eikon: ID:nBSEbwTbNK
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility